Evaluation of serologic screening of blood donors in India reveals a lack of correlation between anti-HBc titer and PCR-amplified HBV DNA

Transfusion

Volumn 43, Issue 10, 2003, Pages 1442-1448

  Chaudhuri, Vaishali ^b   Nanu, Ambika ^a   Panda, Subrat Kumar ^b   Chand, Prem ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIGEN; HEPATITIS B CORE ANTIBODY; VIRUS DNA; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN;

ANTIBODY SCREENING; ANTIBODY TITER; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DETERMINATION; EVALUATION; GENE AMPLIFICATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOREACTIVITY; INDIA; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; SEROLOGY; VIRUS TRANSMISSION; BLOOD; FOLLOW UP; IMMUNOLOGY;

BLOOD DONORS; DNA, VIRAL; FOLLOW-UP STUDIES; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HUMANS; INDIA; SEROLOGIC TESTS;

EID: 0142040259     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2003.00512.x     Document Type: Article

References (21)

1. Dasarathy S, Misra SC, Acharya SK, et al. Prospective controlled study of post transfusion hepatitis after cardiac surgery in a large referral hospital in India. Liver 1992;12:116-20.
2. Saxena R, Thakur V, Sood B, et al. Transfusion-associated hepatitis in a tertiary referral hospital in india. A prospective study. Vox Sang 1999;77:6-10. Erratum Vox Sang 2000;79:20.
3. Choudhury N, Saraswat S, Naveed M. Serological monitoring of thalassaemia major patients for transfusion associated viral infections. Indian J Med Res 1998;107:263-8.
4. Choudhury N, Naik S, Sharma RK, et al. The prevalence of transfusion transmitted diseases in renal transplant recipients. Ind J Path Microbiol 1996;39:191-5.
5. Grob P, Jilg W, Bornhak H, et al. Serological pattern "anti-HBc alone": Report on a workshop. J Med Virol 2000;62:450-5.
6. Yotsuyanagi H, Yasuda K, Moriya K, et al. Frequent presence of HBV in the sera of HBsAg-negative, anti-HBc positive blood donors. Transfusion 2001;41:1093-9.
7. Vyas GN. Significance of HBV DNA in HBsAg negative individuals: a critical commentary. In Sarin SK, Hess G, eds. Transfusion associated hepatitis. Diagnosis, treatment and prevention. New Delhi: CBS Publishers & Distributors, 1998:49-56.
8. Dodd RY, Popovsky MA. Antibodies to hepatitis B core antigen and the infectivity of the blood supply. Scientific Section Coordinating Committee. Transfusion 1991;31:443-9.
9. Lizuka H, Ohmura K, Ishijima A, et al. Correlation between anti HBc titers and HBV DNA in blood units without detectable HBsAg. Vox Sang 1992;63:107-11.
10. Nishioka K. Screening procedures for hepatitis viruses: a cost-benefit approach. In Sarin SK, Hess G, eds. Transfusion associated hepatitis. Diagnosis, treatment and prevention. New Delhi: CBS Publishers & Distributors, 1998:221-6.
11. Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post transfusion hepatitis. Japanese Red Cross Non-A, Non-B Hepatitis Research Group. Lancet 1991;338:1040-1.
12. Kojima M, Shimizu M, Tsuchimochi T, et al. Posttransfusion fulminant hepatitis B associated with precore-defective HBV mutants. Vox Sang 1991;60:34-9.
13. Vyas GN. Algorithm for safe blood with regard to transfusion acquired infections. In: Sarin SK, Hess G, eds. Transfusion associated hepatitis. Diagnosis, treatment and prevention. New Delhi: CBS Publishers & Distributors, 1998:462-78.
14. Panigrahi AK, Nayak B, Dixit R, et al. Evaluation of third generation anti-HCV enzyme immunoassays. Trop Gastroenterol 1998;19:105-7.
15. Larzrul D, Guigue F, Sninsky JJ, et al. Detection of hepatitis B virus sequence in serum by using in-vitro enzymatic amplification. J Virol Methods 1988;20:227-37.
16. Preisler-Adams S, Schlayer HJ, Peters T, et al. Sequence analysis of hepatitis B virus DNA in immunologically negative infection. Arch Virol 1993;133:385-96.
17. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989;339:237-8.
18. Nanu A, Sharma SP, Chatterjee K, Jyoti P. Markers for transfusion-transmissible infections in North Indian voluntary and replacement blood donors: prevalence and trends 1989-1996. Vox Sang 1997;73:70-3.
19. Garg S, Mathur DR, Garg DK. Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary blood donors in western India. Indian J Pathol Microbiol 2001;44:409-12.
20. Srikrishna A, Sitalakshmi S, Damodar P. How safe are our safe donors? Indian J Pathol Microbiol 1999;42:411-6.
21. Luo KX, Zhou R, He C, et al. Hepatitis B virus DNA in sera of virus carriers positive exclusively for antibodies to the hepatitis B core antigen. J Med Virol 1991;35:55-9.